Dysregulated relationship of inflammation and oxidative stress in major depression
- PMID: 23201587
- PMCID: PMC3669232
- DOI: 10.1016/j.bbi.2012.11.011
Dysregulated relationship of inflammation and oxidative stress in major depression
Abstract
Chronic inflammation and oxidative stress have been implicated in the pathophysiology of Major Depressive Disorder (MDD), as well as in a number of chronic medical conditions. The aim of this study was to examine the relationship between peripheral inflammatory and oxidative stress markers in un-medicated subjects with MDD compared to non-depressed healthy controls and compared to subjects with MDD after antidepressant treatment. We examined the relationships between IL-6, IL-10, and the IL-6/IL-10 inflammatory ratio vs. F2-isoprostanes (F2-IsoP), a marker of oxidative stress, in un-medicated MDD patients (n=20) before and after 8 weeks of open-label sertraline treatment (n=17), compared to healthy non-depressed controls (n=20). Among the un-medicated MDD subjects, F2-IsoP concentrations were positively correlated with IL-6 concentrations (p<0.05) and were negatively correlated with IL-10 concentrations (p<0.01). Accordingly, F2-IsoP concentrations were positively correlated with the ratio of IL-6/IL-10 (p<0.01). In contrast, in the control group, there were no significant correlations between F2-IsoPs and either cytokine or their ratio. After MDD subjects were treated with sertraline for 8 weeks, F2-IsoPs were no longer significantly correlated with IL-6, IL-10 or the IL-6/IL-10 ratio. These data suggest oxidative stress and inflammatory processes are positively associated in untreated MDD. Our findings are consistent with the hypothesis that the homeostatic buffering mechanisms regulating oxidation and inflammation in healthy individuals become dysregulated in untreated MDD, and may be improved with antidepressant treatment. These findings may help explain the increased risk of comorbid medical illnesses in MDD.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Oxidative stress, inflammation and treatment response in major depression.Psychoneuroendocrinology. 2017 Feb;76:197-205. doi: 10.1016/j.psyneuen.2016.11.031. Epub 2016 Nov 30. Psychoneuroendocrinology. 2017. PMID: 27960139 Free PMC article.
-
Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort.Psychol Med. 2017 Apr;47(5):936-948. doi: 10.1017/S0033291716002828. Epub 2016 Dec 8. Psychol Med. 2017. PMID: 27928978
-
Increased oxidative stress in patients with depression and its relationship to treatment.Psychiatry Res. 2013 Apr 30;206(2-3):213-6. doi: 10.1016/j.psychres.2012.10.018. Epub 2012 Dec 11. Psychiatry Res. 2013. PMID: 23245537 Free PMC article.
-
Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder.Oxid Med Cell Longev. 2012;2012:609421. doi: 10.1155/2012/609421. Epub 2012 May 27. Oxid Med Cell Longev. 2012. PMID: 22693652 Free PMC article. Review.
-
Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.Mol Psychiatry. 2020 Feb;25(2):339-350. doi: 10.1038/s41380-019-0474-5. Epub 2019 Aug 19. Mol Psychiatry. 2020. PMID: 31427752
Cited by
-
Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias.Brain Behav Immun. 2013 Jul;31:1-8. doi: 10.1016/j.bbi.2013.04.009. Epub 2013 Apr 30. Brain Behav Immun. 2013. PMID: 23639523 Free PMC article.
-
Depression, mitochondrial bioenergetics, and electroconvulsive therapy: a new approach towards personalized medicine in psychiatric treatment - a short review and current perspective.Transl Psychiatry. 2020 Jul 9;10(1):226. doi: 10.1038/s41398-020-00901-7. Transl Psychiatry. 2020. PMID: 32647150 Free PMC article. Review.
-
Anti-Inflammatory, Antioxidant, and Neuroprotective Effects of Polyphenols-Polyphenols as an Element of Diet Therapy in Depressive Disorders.Int J Mol Sci. 2023 Jan 23;24(3):2258. doi: 10.3390/ijms24032258. Int J Mol Sci. 2023. PMID: 36768580 Free PMC article. Review.
-
Peripheral antioxidant markers are associated with total hippocampal and CA3/dentate gyrus volume in MDD and healthy controls-preliminary findings.Psychiatry Res. 2014 Dec 30;224(3):168-74. doi: 10.1016/j.pscychresns.2014.09.002. Epub 2014 Sep 16. Psychiatry Res. 2014. PMID: 25266915 Free PMC article.
-
Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers.Front Psychol. 2014 Aug 26;5:950. doi: 10.3389/fpsyg.2014.00950. eCollection 2014. Front Psychol. 2014. PMID: 25206349 Free PMC article. Review.
References
-
- Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012 http://dx.doi.org/10.1016/j.jad.2012.03.033. - DOI - PubMed
-
- Agrawal NK, Maiti R, Dash D, Pandey BL. Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients. Pharmacol Res. 2007;56(2):118–123. http://dx.doi.org/10.1016/j.phrs.2007.04.007. - DOI - PubMed
-
- Ambade A, Mandrekar P. Oxidative stress and inflammation: essential partners in alcoholic liver disease. Int J Hepatol. 2012;2012:853175. http://dx.doi.org/10.1155/2012/853175. - DOI - PMC - PubMed
-
- Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry. 1999a;4 (2):182–188. - PubMed
-
- Anisman H, Ravindran AV, Griffiths J, Merali Z. Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biol Psychiatry. 1999b;46 (12):1649–1655. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous